Strumenti personali
Logotipo di UniBa

Sezioni

Salta ai contenuti. | Salta alla navigazione

Tu sei qui:HomeDocentiTrojano MariaPubblicazioni

Pubblicazioni

Publications

  

1: Capra R, Battaglia MA, Gaudioso A, Lopes L, Paolicelli D, Paoloni M, Pozzilli

C, Santilli V, Solaro C, Trojano M. The MoSt Project--More Steps in multiple

sclerosis: a Delphi method consensus initiative for the evaluation of mobility

management of MS patients in Italy. J Neurol. 2014 Jan 22.

  

2: Miller DH, Fazekas F, Montalban X, Reingold SC, Trojano M. Pregnancy, sex and

hormonal factors in multiple sclerosis. Mult Scler. 2014 Jan 20.

 

 3: Giordano A, Lugaresi A, Confalonieri P, Granella F, Radice D, Trojano M,

Martinelli V, Solari A; on behalf of the SIMS-Practice groupa. Implementation of

the 'Sapere Migliora' information aid for newly diagnosed people with multiple

sclerosis in routine clinical practice: a late-phase controlled trial. Mult

Scler. 2014 Jan 13.

 

4: Portaccio E, Ghezzi A, Hakiki B, Sturchio A, Martinelli V, Moiola L, Patti F,

Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, De

Luca G, Paolicelli D, Marrosu MG, Comi G, Trojano M, Amato MP; for the MS Study

Group of the Italian Neurological Society. Postpartum relapses increase the risk

of disability progression in multiple sclerosis: the role of disease modifying

drugs. J Neurol Neurosurg Psychiatry. 2014 Jan 8.

 

 5: Bassi M, Falautano M, Cilia S, Goretti B, Grobberio M, Pattini M, Pietrolongo

E, Viterbo RG, Amato MP, Benin M, Lugaresi A, Martinelli V, Montanari E, Patti F,

Trojano M, Delle Fave A. The coexistence of well- and ill-being in persons with

multiple sclerosis, their caregivers and health professionals. J Neurol Sci. 2014

Feb 15;337(1-2):67-73.

  

6: Pisani F, Sparaneo A, Tortorella C, Ruggieri M, Trojano M, Mola MG, Nicchia

GP, Frigeri A, Svelto M. Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4

isoform-dependent sensitivity and specificity. PLoS One. 2013 Nov

15;8(11):e79185.

  

7: Kalincik T, Vivek V, Jokubaitis V, Lechner-Scott J, Trojano M, Izquierdo G,

Lugaresi A, Grand'maison F, Hupperts R, Oreja-Guevara C, Bergamaschi R, Iuliano

G, Alroughani R, Van Pesch V, Amato MP, Slee M, Verheul F, Fernandez-Bolanos R,

Fiol M, Spitaleri DL, Cristiano E, Gray O, Cabrera-Gomez JA, Shaygannejad V,

Herbert J, Vucic S, Needham M, Petkovska-Boskova T, Sirbu CA, Duquette P, Girard

M, Grammond P, Boz C, Giuliani G, Rio ME, Barnett M, Flechter S, Moore F, Singhal

B, Bacile EA, Saladino ML, Shaw C, Skromne E, Poehlau D, Vella N, Spelman T, Liew

D, Kilpatrick TJ, Butzkueven H; MSBase Study Group. Sex as a determinant of

relapse incidence and progressive course of multiple sclerosis. Brain. 2013

Dec;136(Pt 12):3609-17.

 

8: Patti F, Morra VB, Amato MP, Trojano M, Bastianello S, Tola MR, Cottone S,

Plant A, Picconi O; COGIMUS Study Group. Subcutaneous interferon β-1a may protect

against cognitive impairment in patients with relapsing-remitting multiple

sclerosis: 5-year follow-up of the COGIMUS study. PLoS One. 2013 Aug

30;8(8):e74111.

  

9: Tortorella C, Direnzo V, D'Onghia M, Trojano M. Brainstem PML lesion mimicking

MS plaque in a natalizumab-treated MS patient. Neurology. 2013 Oct

15;81(16):1470-1.

 

10: Hughes SE, Spelman T, Gray OM, Boz C, Trojano M, Lugaresi A, Izquierdo G,

Duquette P, Girard M, Grand'maison F, Grammond P, Oreja-Guevara C, Hupperts R,

Bergamaschi R, Giuliani G, Lechner-Scott J, Barnett M, Edite Rio M, Pesch VV,

Amato MP, Iuliano G, Slee M, Verheul F, Cristiano E, Fernández-Bolaños R, Poehlau

D, Saladino ML, Deri N, Cabrera-Gomez J, Vella N, Herbert J, Skromne E, Savino A,

Shaw C, Moore F, Vucic S, Petkovska-Boskova T, McDonnell G, Hawkins SA, Kee F,

Butzkueven H. Predictors and dynamics of postpartum relapses in women with

multiple sclerosis. Mult Scler. 2014 Jan 14.

 

11: Goretti B, Viterbo RG, Portaccio E, Niccolai C, Hakiki B, Piscolla E,

Iaffaldano P, Trojano M, Amato MP. Anxiety state affects information processing

speed in patients with multiple sclerosis. Neurol Sci. 2013 Sep 27.

 

12: Comi G, Battaglia MA, Bertolotto A, Del Sette M, Ghezzi A, Malferrari G,

Salvetti M, Sormani MP, Tesio L, Stolz E, Zaratin P, Mancardi G; CoSMo

Collaborative Study Group. Observational case-control study of the prevalence of

chronic cerebrospinal venous insufficiency in multiple sclerosis: results from

the CoSMo study. Mult Scler. 2013 Oct;19(11):1508-17.

 

 

13: Iaffaldano P, Ruggieri M, Viterbo RG, Mastrapasqua M, Trojano M. The

improvement of cognitive functions is associated with a decrease of plasma

Osteopontin levels in Natalizumab treated relapsing multiple sclerosis. Brain

Behav Immun. 2014 Jan;35:96-101.

  

14: Amato MP, Goretti B, Viterbo RG, Portaccio E, Niccolai C, Hakiki B,

Iaffaldano P, Trojano M. Computer-assisted rehabilitation of attention in

patients with multiple sclerosis: results of a randomized, double-blind trial.

Mult Scler. 2014 Jan;20(1):91-8.

  

15: Filippi M, Rocca MA, Bastianello S, Comi G, Gallo P, Gallucci M, Ghezzi A,

Marrosu MG, Minonzio G, Pantano P, Pozzilli C, Tedeschi G, Trojano M, Falini A,

De Stefano N. Guidelines from The Italian Neurological and Neuroradiological

Societies for the use of magnetic resonance imaging in daily life clinical

practice of multiple sclerosis patients. Neurol Sci. 2013 Dec;34(12):2085-93.

 

 

16: Kalincik T, Spelman T, Trojano M, Duquette P, Izquierdo G, Grammond P,

Lugaresi A, Hupperts R, Cristiano E, Van Pesch V, Grand'maison F, La Spitaleri D,

Rio ME, Flechter S, Oreja-Guevara C, Giuliani G, Savino A, Amato MP, Petersen T,

Fernandez-Bolanos R, Bergamaschi R, Iuliano G, Boz C, Lechner-Scott J, Deri N,

Gray O, Verheul F, Fiol M, Barnett M, van Munster E, Santiago V, Moore F, Slee M,

Saladino ML, Alroughani R, Shaw C, Kasa K, Petkovska-Boskova T, den

Braber-Moerland L, Chapman J, Skromne E, Herbert J, Poehlau D, Needham M, Bacile

EA, Arruda WO, Paine M, Singhal B, Vucic S, Cabrera-Gomez JA, Butzkueven H;

MSBase Study Group. Persistence on therapy and propensity matched outcome

comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis.

PLoS One. 2013 May 21;8(5):e63480.

 

 

17: Viterbo RG, Iaffaldano P, Trojano M. Verbal fluency deficits in clinically

isolated syndrome suggestive of multiple sclerosis. J Neurol Sci. 2013 Jul

15;330(1-2):56-60.

 

 

18: Pietrolongo E, Giordano A, Kleinefeld M, Confalonieri P, Lugaresi A,

Tortorella C, Pugliatti M, Radice D, Goss C, Heesen C, Solari A; AutoMS group.

Decision-making in multiple sclerosis consultations in Italy: third observer and

patient assessments. PLoS One. 2013;8(4):e60721.

 

 

19: Galeotti F, Massari M, D'Alessandro R, Beghi E, Chiò A, Logroscino G,

Filippini G, Benedetti MD, Pugliatti M, Santuccio C, Raschetti R; ITANG study

group. Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination. Eur

J Epidemiol. 2013 May;28(5):433-44.

 

 

20: Girolamo F, Lia A, Amati A, Strippoli M, Coppola C, Virgintino D, Roncali L,

Toscano A, Serlenga L, Trojano M. Overexpression of autophagic proteins in the

skeletal muscle of sporadic inclusion body myositis. Neuropathol Appl Neurobiol.

2013 Mar 4. doi: 10.1111/nan.12040.

 

21: Wolinsky JS, Narayana PA, Nelson F, Datta S, O'Connor P, Confavreux C, Comi

G, Kappos L, Olsson TP, Truffinet P, Wang L, Miller A, Freedman MS; Teriflunomide

Multiple Sclerosis Oral (TEMSO) Trial Group. Magnetic resonance imaging outcomes

from a phase III trial of teriflunomide. Mult Scler. 2013 Sep;19(10):1310-9.

 

 

22: Paolicelli D, D'Onghia M, Pellegrini F, Direnzo V, Iaffaldano P, Lavolpe V,

Trojano M. The impact of neutralizing antibodies on the risk of disease worsening

in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing

study. J Neurol. 2013 Jun;260(6):1562-8.

 

 

23: Ghezzi A, Pozzilli C, Grimaldi LM, Moiola L, Brescia-Morra V, Lugaresi A, Lus

G, Rinaldi F, Rocca MA, Trojano M, Bianchi A, Comi G, Filippi M; Italian MS Study

Group. Natalizumab in pediatric multiple sclerosis: results of a cohort of 55

cases. Mult Scler. 2013 Jul;19(8):1106-12.

 

 

24: Trojano M. Multiple sclerosis spasticity symptoms management. Endocannabinoid

system modulator data beyond clinical trials. Foreword. Expert Rev Neurother.

2013 Feb;13(3 Suppl 1):1.

 

25: Tortorella C, Romano R, Direnzo V, Taurisano P, Zoccolella S, Iaffaldano P,

Fazio L, Viterbo R, Popolizio T, Blasi G, Bertolino A, Trojano M. Load-dependent

dysfunction of the putamen during attentional processing in patients with

clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler. 2013

Aug;19(9):1153-60.

 

 

26: Pugliatti M, Eskic D, Mikolcić T, Pitschnau-Michel D, Myhr KM, Sastre-Garriga

J, Otero S, Wieczynska L, Torje C, Holloway E, Rienhoff O, Friede T, Buckow K,

Ellenberger D, Hillert J, Glaser A, Flachenecker P, Fuge J, Schyns-Liharska T,

Kasilingam E, Moretti A, Thalheim C; EUReMS Consortium. Assess, compare and

enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European

Register for MS. Acta Neurol Scand Suppl. 2012;(195):24-30.

 

 

27: Pastò L, Portaccio E, Ghezzi A, Hakiki B, Giannini M, Razzolini L, Piscolla

E, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, La

Mantia L, Mancardi GL, Solaro C, Totaro R, Tola MR, Di Tommaso V, Lugaresi A,

Moiola L, Martinelli V, Comi G, Amato MP; MS Study Group of the Italian

Neurological Society. Epidural analgesia and cesarean delivery in multiple

sclerosis post-partum relapses: the Italian cohort study. BMC Neurol. 2012 Dec

31;12:165.

 

 

28: Messmer Uccelli M, Traversa S, Trojano M, Viterbo RG, Ghezzi A, Signori A.

Lack of information about multiple sclerosis in children can impact parents'

sense of competency and satisfaction within the couple. J Neurol Sci. 2013 Jan

15;324(1-2):100-5.

 

 

29: Trojano M, Lucchese G, Graziano G, Taylor BV, Simpson S Jr, Lepore V,

Grand'maison F, Duquette P, Izquierdo G, Grammond P, Amato MP, Bergamaschi R,

Giuliani G, Boz C, Hupperts R, Van Pesch V, Lechner-Scott J, Cristiano E, Fiol M,

Oreja-Guevara C, Saladino ML, Verheul F, Slee M, Paolicelli D, Tortorella C,

D'Onghia M, Iaffaldano P, Direnzo V, Butzkueven H; MSBase Study Group and the New

Zealand MS Prevalence Study Group. Geographical variations in sex ratio trends

over time in multiple sclerosis. PLoS One. 2012;7(10):e48078.

 

 

30: Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Piscolla

E, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, La

Mantia L, Mancardi G, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola

L, Martinelli V, Comi G, Amato MP. Pregnancy and fetal outcomes after Glatiramer

Acetate exposure in patients with multiple sclerosis: a prospective observational

multicentric study. BMC Neurol. 2012 Oct 22;12:124.

 

 

31: Verheul F, Smolders J, Trojano M, Lepore V, Zwanikken C, Amato MP,

Grand'maison F, Butzkueven H, Marrosu M, Duquette P, Comi G, Izquierdo G,

Grammond P, Lus G, Petersen T, Bergamaschi R, Giuliani G, Boz C, Coniglio G, Van

Pesch V, Lechner-Scott J, Cavalla P, Granella F, Avolio C, Fiol M, Poehlau D,

Saladino ML, Gallo P, Deri N, Oleschko Arruda W, Paine M, Ferro M, Barnett M,

Cabrera-Gomez JA, Slee M, Moore F, Shaw C, Petkovska-Boskova T, Rutherford M,

Engelsen O, Damoiseaux J, Hupperts R. Fluctuations of MS births and UV-light

exposure. Acta Neurol Scand. 2013 May;127(5):301-8.

 

 

32: Zoccolella S, Tortorella C, Iaffaldano P, Direnzo V, D'Onghia M,

Luciannatelli E, Paolicelli D, Livrea P, Trojano M. Low serum urate levels are

associated to female gender in multiple sclerosis patients. PLoS One.

2012;7(7):e40608.

 

 

 

33: Meyniel C, Spelman T, Jokubaitis VG, Trojano M, Izquierdo G, Grand'Maison F,

Oreja-Guevara C, Boz C, Lugaresi A, Girard M, Grammond P, Iuliano G, Fiol M,

Cabrera-Gomez JA, Fernandez-Bolanos R, Giuliani G, Lechner-Scott J, Cristiano E,

Herbert J, Petkovska-Boskova T, Bergamaschi R, van Pesch V, Moore F, Vella N,

Slee M, Santiago V, Barnett M, Havrdova E, Young C, Sirbu CA, Tanner M,

Rutherford M, Butzkueven H; MSBasis Study Group. Country, sex, EDSS change and

therapy choice independently predict treatment discontinuation in multiple

sclerosis and clinically isolated syndrome. PLoS One. 2012;7(6):e38661.

 

 

34: Bergamaschi R, Quaglini S, Tavazzi E, Amato MP, Paolicelli D, Zipoli V,

Romani A, Tortorella C, Portaccio E, D'Onghia M, Garberi F, Bargiggia V, Trojano

M. Immunomodulatory therapies delay disease progression in multiple sclerosis.

Mult Scler. 2012 May 31.

 

35: Iaffaldano P, Viterbo RG, Paolicelli D, Lucchese G, Portaccio E, Goretti B,

Direnzo V, D'Onghia M, Zoccolella S, Amato MP, Trojano M. Impact of natalizumab

on cognitive performances and fatigue in relapsing multiple sclerosis: a

prospective, open-label, two years observational study. PLoS One.

2012;7(4):e35843.

 

 

36: de Tommaso M, Ceci E, Pica C, Trojano M, Delussi M, Franco G, Livrea P,

Ruggieri M. Serum levels of N-acetyl-aspartate in migraine and tension-type

headache. J Headache Pain. 2012 Jul;13(5):389-94.

 

37: Kister I, Chamot E, Cutter G, Bacon TE, Jokubaitis VG, Hughes SE, Gray OM,

Trojano M, Izquierdo G, Grand'Maison F, Duquette P, Lugaresi A, Grammond P, Boz

C, Hupperts R, Petersen T, Giuliani G, Oreja-Guevara C, Iuliano G, Lechner-Scott

J, Bergamaschi R, Rio ME, Verheul F, Fiol M, Van Pesch V, Slee M, Butzkueven H,

Herbert J; MSBase Investigators. Increasing age at disability milestones among MS

patients in the MSBase Registry. J Neurol Sci. 2012 Jul 15;318(1-2):94-9.

 

 

38: Ciccone MM, Galeandro AI, Scicchitano P, Zito A, Gesualdo M, Sassara M,

Cortese F, Dachille A, Carbonara R, Federico F, Livrea P, Trojano M. Multigate

quality Doppler profiles and morphological/hemodynamic alterations in multiple

sclerosis patients. Curr Neurovasc Res. 2012 May;9(2):120-7.

 

 

39: Cosentino M, Zaffaroni M, Trojano M, Giorelli M, Pica C, Rasini E, Bombelli

R, Ferrari M, Ghezzi A, Comi G, Livrea P, Lecchini S, Marino F. Dopaminergic

modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis

patients during interferon-β therapy. Neuroimmunomodulation. 2012;19(5):283-92.

 

 

40: Zoccolella S, Tortorella C, Iaffaldano P, Direnzo V, D'Onghia M, Paolicelli

D, Livrea P, Trojano M. Elevated plasma homocysteine levels in patients with

multiple sclerosis are associated with male gender. J Neurol. 2012

Oct;259(10):2105-10.

 

 

41: Caragnano M, Tortorella P, Bergami A, Ruggieri M, Livrea P, Specchio LM,

Martino G, Trojano M, Furlan R, Avolio C. Monocytes P2X7 purinergic receptor is

modulated by glatiramer acetate in multiple sclerosis. J Neuroimmunol. 2012

Apr;245(1-2):93-7.

 

 

42: Hughes S, Spelman T, Trojano M, Lugaresi A, Izquierdo G, Grand'maison F,

Duquette P, Girard M, Grammond P, Oreja-Guevara C, Hupperts R, Boz C, Bergamaschi

R, Giuliani G, Rio ME, Lechner-Scott J, van Pesch V, Iuliano G, Fiol M, Verheul

F, Barnett M, Slee M, Herbert J, Kister I, Vella N, Moore F, Petkovska-Boskova T,

Shaygannejad V, Jokubaitis V, McDonnell G, Hawkins S, Kee F, Gray O, Butzkueven

H; MSBase Study Group. The Kurtzke EDSS rank stability increases 4 years after

the onset of multiple sclerosis: results from the MSBase Registry. J Neurol

Neurosurg Psychiatry. 2012 Mar;83(3):305-10.

 

 

43: Lechner-Scott J, Spencer B, de Malmanche T, Attia J, Fitzgerald M, Trojano M,

Grand'Maison F, Gomez JA, Izquierdo G, Duquette P, Girard M, Grammond P,

Oreja-Guevara C, Hupperts R, Bergamaschi R, Boz C, Giuliani G, van Pesch V,

Iuliano G, Fiol M, Cristiano E, Verheul F, Saladino ML, Slee M, Barnett M, Deri

N, Flechter S, Vella N, Shaw C, Herbert J, Moore F, Petkovska-Boskova T,

Jokubaitis V, Butzkueven H; MSBase study group. The frequency of CSF oligoclonal

banding in multiple sclerosis increases with latitude. Mult Scler. 2012

Jul;18(7):974-82.

 

 

44: Iaffaldano P, Lucchese G, Trojano M. Treating multiple sclerosis with

natalizumab. Expert Rev Neurother. 2011 Dec;11(12):1683-92.

 

 

45: Martinelli V, Cocco E, Capra R, Salemi G, Gallo P, Capobianco M, Pesci I,

Ghezzi A, Pozzilli C, Lugaresi A, Bellantonio P, Amato MP, Grimaldi LM, Trojano

M, Mancardi GL, Bergamaschi R, Gasperini C, Rodegher M, Straffi L, Ponzio M, Comi

G; Italian Mitoxantrone Group. Acute myeloid leukemia in Italian patients with

multiple sclerosis treated with mitoxantrone. Neurology. 2011 Nov

22;77(21):1887-95.

 

 

46: Ruggieri M, Serpino C, Ceci E, Sciruicchio V, Franco G, Pica C, Trojano M,

Livrea P, de Tommaso M. Serum levels of N-acetylaspartate in Huntington's

disease: preliminary results. Mov Disord. 2012 Feb;27(2):329-30.

 

 

47: Bastianello S, Giugni E, Amato MP, Tola MR, Trojano M, Galletti S,

Luccichenti G, Quarantelli M, Picconi O, Patti F; COGIMUS study group. Changes in

magnetic resonance imaging disease measures over 3 years in mildly disabled

patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in

the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study. BMC Neurol. 2011

Oct 14;11:125.

 

 

48: O'Connor P, Wolinsky JS, Confavreux C, Comi G, Kappos L, Olsson TP,

Benzerdjeb H, Truffinet P, Wang L, Miller A, Freedman MS; TEMSO Trial Group.

Randomized trial of oral teriflunomide for relapsing multiple sclerosis. N Engl J

Med. 2011 Oct 6;365(14):1293-303.

 

 

49: Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Picconi O, Cilia S,

Cottone S, Grimaldi LM; COGIMUS study group. Longitudinal changes in social

functioning in mildly disabled patients with relapsing-remitting multiple

sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS

(COGnitive Impairment in MUltiple Sclerosis) study (II). Qual Life Res. 2012

Sep;21(7):1111-21.

 

 

50: Goretti B, Portaccio E, Ghezzi A, Lori S, Moiola L, Falautano M, Viterbo R,

Patti F, Vecchio R, Pozzilli C, Bianchi V, Cappiello S, Comi G, Trojano M, Amato

MP; Multiple Sclerosis Study Group of the Italian Neurological Society. Fatigue

and its relationships with cognitive functioning and depression in paediatric

multiple sclerosis. Mult Scler. 2012 Mar;18(3):329-34.

 

 

51: Portaccio E, Ghezzi A, Hakiki B, Martinelli V, Moiola L, Patti F, La Mantia

L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A,

De Luca G, Paolicelli D, Marrosu MG, Comi G, Trojano M, Amato MP; MS Study Group

of the Italian Neurological Society. Breastfeeding is not related to postpartum

relapses in multiple sclerosis. Neurology. 2011 Jul 12;77(2):145-50.

 

 

52: Girolamo F, Ferrara G, Strippoli M, Rizzi M, Errede M, Trojano M, Perris R,

Roncali L, Svelto M, Mennini T, Virgintino D. Cerebral cortex demyelination and

oligodendrocyte precursor response to experimental autoimmune encephalomyelitis.

Neurobiol Dis. 2011 Sep;43(3):678-89.

 

 

53: Martino D, Chiarotti F, Buttiglione M, Cardona F, Creti R, Nardocci N,

Orefici G, Veneselli E, Rizzo R; Italian Tourette Syndrome Study Group. The

relationship between group A streptococcal infections and Tourette syndrome: a

study on a large service-based cohort. Dev Med Child Neurol. 2011

Oct;53(10):951-7.

 

 

54: Tortorella C, Ruggieri M, Di Monte E, Ceci E, Iaffaldano P, Direnzo V,

Mastrapasqua M, Frigeri A, Amato MP, Hakiki B, Ghezzi A, Lugaresi A, De Luca G,

Patti F, D'Amico E, Sola P, Simone AM, Svelto M, Livrea P, Trojano M. Serum and

CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis

optica. J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1355-9.

 

 

55: Giordano A, Granella F, Lugaresi A, Martinelli V, Trojano M, Confalonieri P,

Radice D, Solari A; SIMS-Trial group. Anxiety and depression in multiple

sclerosis patients around diagnosis. J Neurol Sci. 2011 Aug 15;307(1-2):86-91.

 

 

56: Khatri B, Barkhof F, Comi G, Hartung HP, Kappos L, Montalban X, Pelletier J,

Stites T, Wu S, Holdbrook F, Zhang-Auberson L, Francis G, Cohen JA; TRANSFORMS

Study Group. Comparison of fingolimod with interferon beta-1a in

relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS

study. Lancet Neurol. 2011 Jun;10(6):520-9.

 

 

57: Trojano M. Multiple sclerosis: the evolving diagnostic criteria for multiple

sclerosis. Nat Rev Neurol. 2011 May;7(5):251-2.

 

 

58: Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Picconi O, Cilia S,

Cottone S, Centonze D, Gasperini C; COGIMUS Study Group. Quality of life,

depression and fatigue in mildly disabled patients with relapsing-remitting

multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from

the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. Mult Scler. 2011

Aug;17(8):991-1001.

 

 

59: Trojano M, Paolicelli D, Tortorella C, Iaffaldano P, Lucchese G, Di Renzo V,

D'Onghia M. Natural history of multiple sclerosis: have available therapies

impacted long-term prognosis? Neurol Clin. 2011 May;29(2):309-21.

 

 

60: Edan G, Comi G, Le Page E, Leray E, Rocca MA, Filippi M; French–Italian

Mitoxantrone Interferon-beta-1b Trial Group. Mitoxantrone prior to interferon

beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial. J

Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1344-50.

 

 

61: Ruggieri M, Tortorella C, Ceci E, Paolicelli D, Solfrizzi V, Di Bitonto G,

Pica C, Mastrapasqua M, Livrea P, Trojano M. Age-related changes of serum

N-acetyl-aspartate in healthy controls. Age Ageing. 2011 May;40(3):391-5.

 

 

62: Patti F, Amato MP, Trojano M, Solaro C, Pappalardo A, Zipoli V, Portaccio E,

Paolicelli D, Paolillo A, Mennini FS, Marcellusi A, Ricci C, Battaglia MA.

Multiple sclerosis in Italy: cost-of-illness study. Neurol Sci. 2011

Oct;32(5):787-94.

 

 

63: Ghezzi A, Grimaldi LM, Marrosu MG, Pozzilli C, Comi G, Bertolotto A, Trojano

M, Gallo P, Capra R, Centonze D, Millefiorini E, Sotgiu S, Brescia Morra V, Amato

MP, Lugaresi A, Mancardi G, Caputo D, Montanari E, Provinciali L, Durelli L,

Bergamaschi R, Bellantonio P, Tola MR, Cottone S, Savettieri G, Tedeschi G;

MS-SIN Study Group. Natalizumab therapy of multiple sclerosis: recommendations of

the Multiple Sclerosis Study Group--Italian Neurological Society. Neurol Sci.

2011 Apr;32(2):351-8.

 

 

64: Pisani F, Mastrototaro M, Rossi A, Nicchia GP, Tortorella C, Ruggieri M,

Trojano M, Frigeri A, Svelto M. Identification of two major conformational

aquaporin-4 epitopes for neuromyelitis optica autoantibody binding. J Biol Chem.

2011 Mar 18;286(11):9216-24.

 

 

65: Amato MP, Portaccio E, Ghezzi A, Hakiki B, Zipoli V, Martinelli V, Moiola L,

Patti F, La Mantia L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L,

Totaro R, Lugaresi A, Di Tommaso V, Paolicelli D, Marrosu MG, Comi G, Pellegrini

F, Trojano M; MS Study Group of the Italian Neurological Society. Pregnancy and

fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology. 2010

Nov 16;75(20):1794-802.

 

66: Amato MP, Goretti B, Ghezzi A, Lori S, Zipoli V, Moiola L, Falautano M, De

Caro MF, Viterbo R, Patti F, Vecchio R, Pozzilli C, Bianchi V, Roscio M,

Martinelli V, Comi G, Portaccio E, Trojano M; Multiple Sclerosis Study Group of

the Italian Neurological Society. Cognitive and psychosocial features in

childhood and juvenile MS: two-year follow-up. Neurology. 2010 Sep

28;75(13):1134-40.

 

67: Solari A, Martinelli V, Trojano M, Lugaresi A, Granella F, Giordano A,

Messmer Uccelli M, D'Alessandro R, Pucci E, Confalonieri P, Borreani C;

SIMS-Trial group. An information aid for newly diagnosed multiple sclerosis

patients improves disease knowledge and satisfaction with care. Mult Scler. 2010

Nov;16(11):1393-405.

 

68: Solari A, Mattarozzi K, Vignatelli L, Giordano A, Russo PM, Uccelli MM,

D'Alessandro R; SIMS-Trial group; GERONIMUS group. Development and validation of

a patient self-assessed questionnaire on satisfaction with communication of the

multiple sclerosis diagnosis. Mult Scler. 2010 Oct;16(10):1237-47.

 

 

69: Trojano M. Improving combination trials for multiple sclerosis. Lancet

Neurol. 2010 Jul;9(7):646-7.

 

 

70: Goretti B, Ghezzi A, Portaccio E, Lori S, Zipoli V, Razzolini L, Moiola L,

Falautano M, De Caro MF, Viterbo R, Patti F, Vecchio R, Pozzilli C, Bianchi V,

Roscio M, Comi G, Trojano M, Amato MP; Study Group of the Italian Neurological

Society. Psychosocial issue in children and adolescents with multiple sclerosis.

Neurol Sci. 2010 Aug;31(4):467-70.

 

 

71: Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA,

Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F,

Panzara MA, Sandrock AW; SENTINEL Investigators. Natalizumab plus interferon

beta-1a reduces lesion formation in relapsing multiple sclerosis. J Neurol Sci.

2010 May 15;292(1-2):28-35.

 

 

72: Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P,

Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. A

placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N

Engl J Med. 2010 Feb 4;362(5):416-26.

 

 

73: Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J,

Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S,

Aradhye S, Kappos L; TRANSFORMS Study Group. Oral fingolimod or intramuscular

interferon for relapsing multiple sclerosis. N Engl J Med. 2010 Feb

4;362(5):402-15.

 

 

74: Patti F, Amato MP, Bastianello S, Caniatti L, Di Monte E, Ferrazza P, Goretti

B, Gallo P, Morra VB, Lo Fermo S, Picconi O, Tola MR, Trojano M; COGIMUS Study

Group. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a

on cognitive decline in mildly disabled patients with relapsing-remitting

multiple sclerosis. Mult Scler. 2010 Jan;16(1):68-77.

 

 

75: Giordano A, Uccelli MM, Pucci E, Martinelli V, Borreani C, Lugaresi A,

Trojano M, Granella F, Confalonieri P, Radice D, Solari A; SIMS-Trial group. The

Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for

recently diagnosed patients. Mult Scler. 2010 Jan;16(1):100-11.

 

 

76: Iaffaldano P, D'Onghia M, Trojano M. Safety profile of Tysabri: international

risk management plan. Neurol Sci. 2009 Oct;30 Suppl 2:S159-62.

 

 

77: Trojano M, Pellegrini F, Paolicelli D, Fuiani A, Di Renzo V. observational

studies: propensity score analysis of non-randomized data. Int MS J. 2009

Sep;16(3):90-7.

 

78: Petzold A, Altintas A, Andreoni L, Bartos A, Berthele A, Blankenstein MA,

Buee L, Castellazzi M, Cepok S, Comabella M, Constantinescu CS, Deisenhammer F,

Deniz G, Erten G, Espiño M, Fainardi E, Franciotta D, Freedman MS, Giedraitis V,

Gilhus NE, Giovannoni G, Glabinski A, Grieb P, Hartung HP, Hemmer B, Herukka SK,

Hintzen R, Ingelsson M, Jackson S, Jacobsen S, Jafari N, Jalosinski M, Jarius S,

Kapaki E, Kieseier BC, Koel-Simmelink MJ, Kornhuber J, Kuhle J, Kurzepa J, Lalive

PH, Lannfelt L, Lehmensiek V, Lewczuk P, Livrea P, Marnetto F, Martino D, Menge

T, Norgren N, Papuć E, Paraskevas GP, Pirttilä T, Rajda C, Rejdak K, Ricny J,

Ripova D, Rosengren L, Ruggieri M, Schraen S, Shaw G, Sindic C, Siva A, Stigbrand

T, Stonebridge I, Topcular B, Trojano M, Tumani H, Twaalfhoven HA, Vécsei L, Van

Pesch V, Vanderstichele H, Vedeler C, Verbeek MM, Villar LM, Weissert R,

Wildemann B, Yang C, Yao K, Teunissen CE. Neurofilament ELISA validation. J

Immunol Methods. 2010 Jan 31;352(1-2):23-31.

 

 

79: Trojano M, Pellegrini F, Paolicelli D, Fuiani A, Zimatore GB, Tortorella C,

Simone IL, Patti F, Ghezzi A, Zipoli V, Rossi P, Pozzilli C, Salemi G, Lugaresi

A, Bergamaschi R, Millefiorini E, Clerico M, Lus G, Vianello M, Avolio C, Cavalla

P, Lepore V, Livrea P, Comi G, Amato MP; Italian Multiple Sclerosis Database

Network (MSDN) Group. Real-life impact of early interferon beta therapy in

relapsing multiple sclerosis. Ann Neurol. 2009 Oct;66(4):513-20.

 

 

80: Vukusic S, Ionescu I, El-Etr M, Schumacher M, Baulieu EE, Cornu C, Confavreux

C; Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple

Sclerosis Study Group. The Prevention of Post-Partum Relapses with Progestin and

Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and

state of advancement. J Neurol Sci. 2009 Nov 15;286(1-2):114-8.

 

 

81: O'Connor P, Filippi M, Arnason B, Comi G, Cook S, Goodin D, Hartung HP,

Jeffery D, Kappos L, Boateng F, Filippov V, Groth M, Knappertz V, Kraus C,

Sandbrink R, Pohl C, Bogumil T; BEYOND Study Group, O'Connor P, Filippi M,

Arnason B, Cook S, Goodin D, Hartung HP, Kappos L, Jeffery D, Comi G. 250 microg

or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in

relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre

study. Lancet Neurol. 2009 Oct;8(10):889-97. doi: 10.1016/S1474-4422(09)70226-1.

Epub 2009 Sep 2. Erratum in: Lancet Neurol. 2011 Feb;10(2):115. Lancet Neurol.

2009 Nov;8(11):981. Lancet Neurol. 2012 Jan;11(1):27.

 

 

82: Paolicelli D, Direnzo V, Trojano M. Review of interferon beta-1b in the

treatment of early and relapsing multiple sclerosis. Biologics. 2009;3:369-76.

 

83: Trojano M, Pellegrini F, Paolicelli D, Fuiani A, Zimatore GB, Tortorella C,

Simone IL, Patti F, Ghezzi A, Portaccio E, Rossi P, Pozzilli C, Salemi G,

Lugaresi A, Bergamaschi R, Millefiorini E, Clerico M, Lus G, Vianello M, Avolio

C, Cavalla P, Iaffaldano P, Direnzo V, D'Onghia M, Lepore V, Livrea P, Comi G,

Amato MP; Italian Multiple Sclerosis Database Network Group. Post-marketing of

disease modifying drugs in multiple sclerosis: an exploratory analysis of gender

effect in interferon beta treatment. J Neurol Sci. 2009 Nov 15;286(1-2):109-13.

 

84: Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L,

Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G;

COGIMUS Study Group. Cognitive impairment and its relation with disease measures

in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline

results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult

Scler. 2009 Jul;15(7):779-88.

 

 

85: Ghezzi A, Amato MP, Annovazzi P, Capobianco M, Gallo P, La Mantia L, Marrosu

MG, Martinelli V, Milani N, Moiola L, Patti F, Pozzilli C, Trojano M, Zaffaroni

M, Comi G; ITEMS (Immunomodulatory Treatment of Early-onset MS) Group. Long-term

results of immunomodulatory treatment in children and adolescents with multiple

sclerosis: the Italian experience. Neurol Sci. 2009 Jun;30(3):193-9.

 

 

86: Trojano M, Avolio C. Epstein-Barr virus (EBV) and multiple sclerosis

association: EBV has a primary or secondary role? J Neurol Neurosurg Psychiatry.

2009 May;80(5):469.

 

87: Hussain H, Usman A, Raza Q, Amato MP, Goretti B, Ghezzi A, Lori S, Zipoli V,

Portaccio E, Moiola L, Falautano M, De Caro MF, Lopez M, Patti F, Vecchio R,

Pozzilli C, Bianchi V, Roscio M, Comi G, Trojano M. Cognitive and psychosocial

features of childhood and juvenile MS. Neurology. 2009 Mar 31;72(13):1189; author

reply1189-90.

 

88: Portaccio E, Goretti B, Lori S, Zipoli V, Centorrino S, Ghezzi A, Patti F,

Bianchi V, Comi G, Trojano M, Amato MP; Multiple Sclerosis Study Group of the

Italian Neurological Society. The brief neuropsychological battery for children:

a screening tool for cognitive impairment in childhood and juvenile multiple

sclerosis. Mult Scler. 2009 May;15(5):620-6.

 

 

89: Patti F, Amato MP, Bastianello S, Caniatti L, Di Monte E, Lijoi F, Goretti B,

Messina S, Picconi O, Tola MR, Trojano M. Subcutaneous Interferon Beta-1a Has a

Positive Effect on Cognitive Performance in Mildly Disabled Patients with

Relapsing-Remitting Multiple Sclerosis: 2-Year Results from the COGIMUS Study.

Ther Adv Neurol Disord. 2009 Mar;2(2):67-77.

 

 

90: Nicchia GP, Mastrototaro M, Rossi A, Pisani F, Tortorella C, Ruggieri M, Lia

A, Trojano M, Frigeri A, Svelto M. Aquaporin-4 orthogonal arrays of particles are

the target for neuromyelitis optica autoantibodies. Glia. 2009

Oct;57(13):1363-73.

 

91: Bellomi F, Bramanti P, Trojano M, Scagnolari C, Muto A, Sessa E, La Volpe V,

Russo P, Antonelli G. Neutralizing and binding antibodies to interferon beta in

patients with multiple sclerosis: a comparison of assay results from three

italian centres. J Immunoassay Immunochem. 2009;30(1):40-50.

 

 

92: Trojano M, Paolicelli D, Fuiani A, Pellegrini F, Iaffaldano P, Direnzo V,

D'Onghia M. Postmarketing evidence of disease-modifying drugs in multiple

sclerosis. Neurol Sci. 2008 Sep;29 Suppl 2:S225-6.

 

 

93: Mikol DD, Barkhof F, Chang P, Coyle PK, Jeffery DR, Schwid SR, Stubinski B,

Uitdehaag B; REGARD study group. Comparison of subcutaneous interferon beta-1a

with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif

vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre,

randomised, parallel, open-label trial. Lancet Neurol. 2008 Oct;7(10):903-14.

 

 

94: Cocco E, Sardu C, Gallo P, Capra R, Amato MP, Trojano M, Uccelli A, Marrosu

MG; FEMIMS Group. Frequency and risk factors of mitoxantrone-induced amenorrhea

in multiple sclerosis: the FEMIMS study. Mult Scler. 2008 Nov;14(9):1225-33.

 

 

95: Italian REMS Study Group, Manconi M, Ferini-Strambi L, Filippi M, Bonanni E,

Iudice A, Murri L, Gigli GL, Fratticci L, Merlino G, Terzano G, Granella F,

Parrino L, Silvestri R, Aricò I, Dattola V, Russo G, Luongo C, Cicolin A, Tribolo

A, Cavalla P, Savarese M, Trojano M, Ottaviano S, Cirignotta F, Simioni V, Salvi

F, Mondino F, Perla F, Chinaglia G, Zuliani C, Cesnik E, Granieri E, Placidi F,

Palmieri MG, Manni R, Terzaghi M, Bergamaschi R, Rocchi R, Ulivelli M, Bartalini

S, Ferri R, Lo Fermo S, Ubiali E, Viscardi M, Rottoli M, Nobili L, Protti A,

Ferrillo F, Allena M, Mancardi G, Guarnieri B, Londrillo F. Multicenter

case-control study on restless legs syndrome in multiple sclerosis: the REMS

study. Sleep. 2008 Jul;31(7):944-52.

 

 

96: Ruggieri M, Pica C, Lia A, Zimatore GB, Modesto M, Di Liddo E, Specchio LM,

Livrea P, Trojano M, Avolio C. Combination treatment of Glatiramer Acetate and

Minocycline affects phenotype expression of blood monocyte-derived dendritic

cells in Multiple Sclerosis patients. J Neuroimmunol. 2008 Jul 15;197(2):140-6.

 

 

97: Ramunni A, De Robertis F, Brescia P, Saliani MT, Amoruso M, Prontera M,

Dimonte E, Trojano M, Coratelli P. A case report of double filtration

plasmapheresis in an acute episode of multiple sclerosis. Ther Apher Dial. 2008

Jun;12(3):250-4.

 

98: Cappellano G, Orilieri E, Comi C, Chiocchetti A, Bocca S, Boggio E,

Bernardone IS, Cometa A, Clementi R, Barizzone N, D'Alfonso S, Corrado L,

Galimberti D, Scarpini E, Guerini FR, Caputo D, Paolicelli D, Trojano M,

Figà-Talamanca L, Salvetti M, Perla F, Leone M, Monaco F, Dianzani U. Variations

of the perforin gene in patients with multiple sclerosis. Genes Immun. 2008

Jul;9(5):438-44.

 

 

99: Amato MP, Goretti B, Ghezzi A, Lori S, Zipoli V, Portaccio E, Moiola L,

Falautano M, De Caro MF, Lopez M, Patti F, Vecchio R, Pozzilli C, Bianchi V,

Roscio M, Comi G, Trojano M; Multiple Sclerosis Study Group of the Italian

Neurological Society. Cognitive and psychosocial features of childhood and

juvenile MS. Neurology. 2008 May 13;70(20):1891-7.

 

 

100: D'Alfonso S, Bolognesi E, Guerini FR, Barizzone N, Bocca S, Ferrante D,

Castelli L, Bergamaschi L, Agliardi C, Ferrante P, Naldi P, Leone M, Caputo D,

Ballerini C, Salvetti M, Galimberti D, Massacesi L, Trojano M,

Momigliano-Richiardi P. A sequence variation in the MOG gene is involved in

multiple sclerosis susceptibility in Italy. Genes Immun. 2008 Jan;9(1):7-15.

 

 

101: Trojano M. Is it time to use observational data to estimate treatment

effectiveness in multiple sclerosis? Neurology. 2007 Oct 9;69(15):1478-9.

 

 

102: Ruggieri M, Avolio C, Livrea P, Trojano M. Glatiramer acetate in multiple

sclerosis: a review. CNS Drug Rev. 2007 Summer;13(2):178-91. Review.

 

 

103: Solari A, Acquarone N, Pucci E, Martinelli V, Marrosu MG, Trojano M,

Borreani C, Messmer Uccelli M. Communicating the diagnosis of multiple sclerosis

- a qualitative study. Mult Scler. 2007 Jul;13(6):763-9.

 

 

104: Ghezzi A, Amato MP, Capobianco M, Gallo P, Marrosu MG, Martinelli V,

Milanese C, Moiola L, Milani N, La Mantia L, Patti F, Pozzilli C, Trojano M, Comi

G, Zaffaroni M; Immunomodulatory Treatment of Early-onset MS (ITEMS) Group.

Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a:

long-term results. Neurol Sci. 2007 Jun;28(3):127-32.

 

 

105: Trojano M, Pellegrini F, Fuiani A, Paolicelli D, Zipoli V, Zimatore GB, Di

Monte E, Portaccio E, Lepore V, Livrea P, Amato MP. New natural history of

interferon-beta-treated relapsing multiple sclerosis. Ann Neurol. 2007

Apr;61(4):300-6.

 

106: Patti F, Amato MP, Battaglia MA, Pitaro M, Russo P, Solaro C, Trojano M.

Caregiver quality of life in multiple sclerosis: a multicentre Italian study.

Mult Scler. 2007 Apr;13(3):412-9.

 

107: Scagnolari C, Duda P, Bagnato F, De Vito G, Alberelli A, Lavolpe V, Girardi

E, Durastanti V, Trojano M, Kappos L, Antonelli G. Pharmacodynamics of interferon

beta in multiple sclerosis patients with or without serum neutralizing

antibodies. J Neurol. 2007 May;254(5):597-604.

 

 

108: Giorelli M, Livrea P, Minervini MG, Trojano M. Immunomodulatory properties

of increased levels of liver X receptor beta in peripheral blood mononuclear

cells from multiple sclerosis patients. Exp Neurol. 2007 Apr;204(2):759-66.

 

109: Amato MP, Portaccio E, Goretti B, Zipoli V, Ricchiuti L, De Caro MF, Patti

F, Vecchio R, Sorbi S, Trojano M. The Rao's Brief Repeatable Battery and Stroop

Test: normative values with age, education and gender corrections in an Italian

population. Mult Scler. 2006 Dec;12(6):787-93.

 

110: Butzkueven H, Chapman J, Cristiano E, Grand'Maison F, Hoffmann M, Izquierdo

G, Jolley D, Kappos L, Leist T, Pöhlau D, Rivera V, Trojano M, Verheul F,

Malkowski JP. MSBase: an international, online registry and platform for

collaborative outcomes research in multiple sclerosis. Mult Scler. 2006

Dec;12(6):769-74.

 

111: Bergamaschi R, Quaglini S, Trojano M, Amato MP, Tavazzi E, Paolicelli D,

Zipoli V, Romani A, Fuiani A, Portaccio E, Berzuini C, Montomoli C, Bastianello

S, Cosi V. Early prediction of the long term evolution of multiple sclerosis: the

Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score. J Neurol Neurosurg

Psychiatry. 2007 Jul;78(7):757-9.

 

 

112: Trojano M, Russo P, Fuiani A, Paolicelli D, Di Monte E, Granieri E, Rosati

G, Savettieri G, Comi G, Livrea P; MSDN Study Group. The Italian Multiple

Sclerosis Database Network (MSDN): the risk of worsening according to IFNbeta

exposure in multiple sclerosis. Mult Scler. 2006 Oct;12(5):578-85.

 

 

113: Trojano M, Paolicelli D, Lepore V, Fuiani A, Di Monte E, Pellegrini F, Russo

P, Livrea P, Comi G; Italian MSDN Group. Italian Multiple Sclerosis Database

Network. Neurol Sci. 2006 Sep;27 Suppl 5:S358-61.

 

114: Games Collaborative Group, Ban M, Booth D, Heard R, Stewart G, Goris A,

Vandenbroeck K, Dubois B, Laaksonen M, Ilonen J, Alizadeh M, Edan G, Babron MC,

Brassat D, Clanet M, Cournu-Rebeix I, Fontaine B, Semana G, Goedde R, Epplen J,

Weber A, Infante-Duarte C, Zipp F, Rajda C, Bencsik K, Vécsei L, Heggarty S,

Graham C, Hawkins S, Liguori M, Momigliano-Richiardi P, Caputo D, Grimaldi LM,

Leone M, Massacesi L, Milanese C, Salvetti M, Savettieri G, Trojano M, Bielecki

B, Mycko MP, Selmaj K, Santos M, Maciel P, Pereira C, Silva A, Silva BM, Coraddu

F, Marrosu MG, Akesson E, Hillert J, Datta P, Oturai A, Harbo HF, Spurkland A,

Goertsches R, Villoslada P, Eraksoy M, Hensiek A, Compston A, Setakis E, Gray J,

Yeo TW, Sawcer S. Linkage disequilibrium screening for multiple sclerosis

implicates JAG1 and POU2AF1 as susceptibility genes in Europeans. J Neuroimmunol.

2006 Oct;179(1-2):108-16.

 

 

115: Amato MP, Zipoli V, Goretti B, Portaccio E, De Caro MF, Ricchiuti L,

Siracusa G, Masini M, Sorbi S, Trojano M. Benign multiple sclerosis: cognitive,

psychological and social aspects in a clinical cohort. J Neurol. 2006

Aug;253(8):1054-9.

 

116: Nocentini U, Pasqualetti P, Bonavita S, Buccafusca M, De Caro MF, Farina D,

Girlanda P, Le Pira F, Lugaresi A, Quattrone A, Reggio A, Salemi G, Savettieri G,

Tedeschi G, Trojano M, Valentino P, Caltagirone C. Cognitive dysfunction in

patients with relapsing-remitting multiple sclerosis. Mult Scler. 2006

Feb;12(1):77-87.

 

117: Trojano M, Paolicelli D, Zimatore GB, De Robertis F, Fuiani A, Di Monte E,

Livrea P. The IFNbeta treatment of multiple sclerosis (MS) in clinical practice:

the experience at the MS Center of Bari, Italy. Neurol Sci. 2005 Dec;26 Suppl

4:S179-82.

 

 

118: Tortorella C, Bellacosa A, Paolicelli D, Fuiani A, Di Monte E, Simone IL,

Giaquinto P, Livrea P, Trojano M. Age-related gadolinium-enhancement of MRI brain

lesions in multiple sclerosis. J Neurol Sci. 2005 Dec 15;239(1):95-9.

 

 

119: Ruggieri M, Avolio C, Scacco S, Pica C, Lia A, Zimatore GB, Papa S, Livrea

P, Trojano M. Glatiramer acetate induces pro-apoptotic mechanisms involving

Bcl-2, Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients.

J Neurol. 2006 Feb;253(2):231-6.

 

120: Avolio C, Filippi M, Tortorella C, Rocca MA, Ruggieri M, Agosta F, Tomassini

V, Pozzilli C, Stecchi S, Giaquinto P, Livrea P, Trojano M. Serum MMP-9/TIMP-1

and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different

magnetic resonance imaging measures of disease activity during IFN-beta-1a

treatment. Mult Scler. 2005 Aug;11(4):441-6.

 

121: Ghezzi A, Amato MP, Capobianco M, Gallo P, Marrosu G, Martinelli V, Milani

N, Milanese C, Moiola L, Patti F, Pilato V, Pozzilli C, Trojano M, Zaffaroni M,

Comi G; Immunomodulatory Treatment of Early onset MS Group. Disease-modifying

drugs in childhood-juvenile multiple sclerosis: results of an Italian

co-operative study. Mult Scler. 2005 Aug;11(4):420-4.

 

122: Giorelli M, Livrea P, Trojano M. Dopamine fails to regulate activation of

peripheral blood lymphocytes from multiple sclerosis patients: effects of

IFN-beta. J Interferon Cytokine Res. 2005 Jul;25(7):395-406.

 

 

123: Chiocchetti A, Comi C, Indelicato M, Castelli L, Mesturini R, Bensi T,

Mazzarino MC, Giordano M, D'Alfonso S, Momigliano-Richiardi P, Liguori M, Zorzon

M, Amoroso A, Trojano M, Monaco F, Leone M, Magnani C, Dianzani U. Osteopontin

gene haplotypes correlate with multiple sclerosis development and progression. J

Neuroimmunol. 2005 Jun;163(1-2):172-8.

 

124: Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S,

Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S,

Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F,

Miterski B, Epplen JT, Oturai A, Sørensen PS, Celius EG, Lara NT, Montalban X,

Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H,

Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sá M, Salemi G, Savettieri G, Hillert

J, Compston DA. Multiple Sclerosis Severity Score: using disability and disease

duration to rate disease severity. Neurology. 2005 Apr 12;64(7):1144-51.

 

 

125: Sisto D, Trojano M, Vetrugno M, Trabucco T, Iliceto G, Sborgia C.

Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs,

frequency-doubling perimetry, standard perimetry, and contrast sensitivity.

Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1264-8.

 

126: Ghezzi A, Ruggieri M, Trojano M, Filippi M; ITEMS Study Group. Italian

studies on early-onset multiple sclerosis: the present and the future. Neurol

Sci. 2004 Nov;25 Suppl 4:S346-9.

 

127: Trojano M, Paolicelli D, Bellacosa A, Fuiani A, Cataldi S, Di Monte E.

Atypical forms of multiple sclerosis or different phases of a same disease?

Neurol Sci. 2004 Nov;25 Suppl 4:S323-5.

 

128: Amato MP, Grimaud J, Achiti I, Bartolozzi ML, Adeleine P, Hartung HP, Kappos

L, Thompson A, Trojano M, Vukusic S, Confavreux C; Evaluation of the EDMUS system

(EVALUED) Study Group. European validation of a standardized clinical description

of multiple sclerosis. J Neurol. 2004 Dec;251(12):1472-80.

 

129: Trojano M. Can databasing optimise patient care? J Neurol. 2004 Sep;251

Suppl 5:v79-v82.

 

130: Savettieri G, Messina D, Andreoli V, Bonavita S, Caltagirone C, Cittadella

R, Farina D, Fazio MC, Girlanda P, Le Pira F, Liguori M, Lugaresi A, Nocentini U,

Reggio A, Salemi G, Tedeschi G, Trojano M, Valentino P, Quattrone A.

Gender-related effect of clinical and genetic variables on the cognitive

impairment in multiple sclerosis. J Neurol. 2004 Oct;251(10):1208-14.

 

 

131: Solaro C, Brichetto G, Amato MP, Cocco E, Colombo B, D'Aleo G, Gasperini C,

Ghezzi A, Martinelli V, Milanese C, Patti F, Trojano M, Verdun E, Mancardi GL;

PaIMS Study Group. The prevalence of pain in multiple sclerosis: a multicenter

cross-sectional study. Neurology. 2004 Sep 14;63(5):919-21.

 

 

132: Giorelli M, Livrea P, Trojano M. Post-receptorial mechanisms underlie

functional disregulation of beta2-adrenergic receptors in lymphocytes from

Multiple Sclerosis patients. J Neuroimmunol. 2004 Oct;155(1-2):143-9.

 

 

133: Patti F, Amato MP, Filippi M, Gallo P, Trojano M, Comi GC. A double blind,

placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24

months in patients affected by multiple sclerosis on a background therapy with

interferon-beta study denomination: CYCLIN. J Neurol Sci. 2004 Aug

15;223(1):69-71.

 

134: Cosentino M, Zaffaroni M, Giorelli M, Marino F, Ferrari M, Bombelli R,

Rasini E, Trojano M, Lecchini S, Livrea P, Comi G, Frigo G. Adrenergic mechanisms

in multiple sclerosis: the neuro-immune connection? Trends Pharmacol Sci. 2004

Jul;25(7):350-1; author reply 351-2.

 

135: Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E,

Mancardi L, Gallo P, Filippi M, Zaffaroni M, Comi G; Italian Devic's Study Group

(IDESG). Clinical characteristics, course and prognosis of relapsing Devic's

Neuromyelitis Optica. J Neurol. 2004 Jan;251(1):47-52.

 

136: Liguori M, Cittadella R, Manna I, Valentino P, La Russa A, Serra P, Trojano

M, Messina D, Ruscica F, Andreoli V, Romeo N, Livrea P, Quattrone A. Association

between Synapsin III gene promoter polymorphisms and multiple sclerosis. J

Neurol. 2004 Feb;251(2):165-70.

 

 

Pubblicato il: 20/02/2014